10:06 AM EST - Microbix Biosystems Inc. : Announces that one of its clients is presenting results of Microbix made quality assessment products that help enable full-process quality management of molecular assays to detect human papillomavirus at 2026 PASCV. Microbix Biosystems Inc.
shares T.MBX are trading up $0.01 at $0.25.
